Results of Concurrent Patch Testing of Brazilian and Chinese Propolis.

Emma M van Oers, Norbertus A Ipenburg, Anton de Groot, Evelyn Calta, Thomas Rustemeyer
Author Information
  1. Emma M van Oers: Amsterdam University Medical Centers, Amsterdam, The Netherlands.
  2. Norbertus A Ipenburg: Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. ORCID
  3. Anton de Groot: Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. ORCID
  4. Evelyn Calta: Kurt Kitzing GmbH, Wallerstein, Germany.
  5. Thomas Rustemeyer: Dermato-Allergology and Occupational Dermatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. ORCID

Abstract

BACKGROUND: In Amsterdam, a steep increase in positive reactions to propolis in the European baseline series was observed from 2.8% in 2020 to 16.4% in 2023. We hypothesised that this was caused by the replacement of Chinese propolis by Brazilian propolis.
OBJECTIVES: To test this hypothesis and to compare rates of positive patch tests to Brazilian propolis with those to Chinese popolis.
PATIENTS AND METHODS: In a prospective study, 2 commercial Chinese propolis patch test samples were tested in consecutive patients in addition to Brazilian propolis.
RESULTS: Of 239 patients patch tested, 57 (23.8%) had a positive reaction to Brazilian propolis, and 9 (3.8%) to Chinese propolis. Of the 57 reactions to Brazilian propolis, only 2 (3.5%) were found to be clinically relevant, versus 3/9 (33.3%) for Chinese propolis. Patients reacting to Brazilian propolis had significantly more co-reactivities to fragrance mixes 1 and 2 and to limonene hydroperoxides than propolis B-negative individuals.
CONCLUSIONS: The results confirm our hypothesis that the observed increase in positive patch tests to propolis between 2020 and 2023 was the result of the switch from Chinese to Brazilian propolis. The rates of reactions to both propolis samples from China were significantly lower than to Brazilian propolis.

Keywords

References

  1. G. Kocabas, N. A. Ipenburg, A. de Groot, and T. Rustemeyer, ���Results of Patch Testing Propolis in the European Baseline Series: A 4���Year Retrospective Study,��� Contact Dermatitis 91, no. 5 (2024): 375���378, https://doi.org/10.1111/cod.14678.
  2. J. D. Johansen, K. Aalto���Korte, T. Agner, et al., ���European Society of Contact Dermatitis Guideline for Diagnostic Patch Testing ��� Recommendations on Best Practice,��� Contact Dermatitis 73 (2015): 195���221, https://doi.org/10.1111/cod.12432.
  3. A. C. De Groot, ���Propolis: A Review of Properties, Applications, Chemical Composition, Contact Allergy, and Other Adverse Effects,��� Dermatitis 24, no. 6 (2013): 263���282, https://doi.org/10.1097/DER.0000000000000011.
  4. K. Piontek, S. Radonjic���Hoesli, J. Grabbe, et al., ���Comparison of Patch Testing Brazilian (Green) Propolis and Chinese (Poplar���Type) Propolis: Clinical Epidemiological Study Using Data From the Information Network of Departments of Dermatology (IVDK),��� Contact Dermatitis 92, no. 3 (2025): 209���216, https://doi.org/10.1111/cod.14701.
  5. A. Antelmi, I. Trave, R. Gallo, et al., ���Can Patch Testing With Propolis Be Improved?,��� Contact Dermatitis 91, no. 1 (2024): 53.
  6. S. Schubert, J. Geier, H. Dickel, T. Buhl, F. Ru��ff, and H. L��ffler, ���Contact Sensitization to Propolis in the Information Network of Departments of Dermatology (IVDK) 2013 to 2019 and Market Survey of Propolis Commerce in Germany,��� Contact Dermatitis 85, no. 6 (2021): 722���724, https://doi.org/10.1111/cod.13960.
  7. R. O. Orsi, D. C. B. Barros, R. C. M. Silva, J. V. Queiroz, W. L. P. Araujo, and A. J. Shinohara, ���Toxic Metals in the Crude Propolis and Its Transfer Rate to the Ethanolic Extract,��� Sociobiology 65, no. 4 (2018): 640���644, https://doi.org/10.13102/sociobiology.v65i4.3379.

Word Cloud

Created with Highcharts 10.0.0propolisBrazilianChinese2positivepatchreactions8%fragranceincreaseobserved20202023testhypothesisratestestssamplestestedpatients573significantly1mixBACKGROUND:AmsterdamsteepEuropeanbaselineseries164%hypothesisedcausedreplacementOBJECTIVES:comparepopolisPATIENTSANDMETHODS:prospectivestudycommercialconsecutiveadditionRESULTS:23923reaction95%foundclinicallyrelevantversus3/9333%Patientsreactingco-reactivitiesmixeslimonenehydroperoxidesB-negativeindividualsCONCLUSIONS:resultsconfirmresultswitchChinalowerResultsConcurrentPatchTestingPropolisMyroxylonpereiraeresinallergiccontactdermatitisbeegluecolophoniumfragrances

Similar Articles

Cited By

No available data.